Claire Saxton and Lauren Kriegel of Cancer Support Community, the largest professionally led non-profit network of cancer support worldwide, discuss how cancer patient and caregiver perspectives need to be better integrated into the treatment process. This is an especially prescient issue for next-generation cell and gene therapies such as CAR-T which, as Saxton and Kreigel outline, require greater levels of patient access and associated support programs.
If companies bring in the patient perspective from the beginning, the insights they gain could make their clinical trial process go quicker and create a better understanding of how patients make decisions between different treatment options
